Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Pancreatic Cancer
100%
Innate Immunity
100%
CD11b
100%
Immunosuppressive Myeloid Cells
100%
Agonism
100%
Cell Response
66%
Monocytes
66%
Granulocytes
66%
Checkpoint Immunotherapy
66%
Resistance to Immunotherapy
66%
Dendritic Cells
33%
Myeloid Cells
33%
Antitumor T Cells
33%
Cancer Types
33%
Cell Behavior
33%
Cell Infiltration
33%
Tumor Subtype
33%
Malignancy
33%
Cell Surface
33%
Cancer Treatment
33%
Integrin
33%
Untargeted
33%
Tumor-infiltrating
33%
Therapeutic Efficacy
33%
CD18
33%
Lack of Response
33%
Cell Subsets
33%
Partial Activation
33%
Strategies to Overcome
33%
Repolarization
33%
Tissue-resident Macrophages
33%
Macrophage Survival
33%
Ongoing Clinical Trials
33%
Resistance Mechanisms
33%
Tumor-associated Macrophages
33%
T Cell Immunity
33%
Checkpoint Inhibitors
33%
Small Molecule Agonist
33%
Inflamed Tissue
33%
Overcoming Resistance
33%
Clinical Strategies
33%
Response to Immunotherapy
33%
Compensatory Actions
33%
Immunology and Microbiology
Immunotherapy
100%
Innate Immune System
100%
Myeloid
66%
Immunosuppressive Drug
50%
Granulocyte
33%
Macrophage
33%
Dendritic Cell
16%
Tumor-Associated Macrophage
16%
Cell Function
16%
Cell Surface
16%
Agonist
16%
Adoptive Immunity
16%
CD18
16%
Cell Infiltration
16%
Preclinical Study
16%
Repolarization
16%
Integrin
16%
Vasopressin
16%